ArticlePharmaceuticals (Basel, Switzerland)2025

Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study.

Nicola Sgherza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.